Pharmacokinetic Evaluation of Published Studies on Controlled Smoking of Marijuana
|
|
- Randall Hunter
- 6 years ago
- Views:
Transcription
1 Pharmacokinetic Evaluation of Published Studies on Controlled Smoking of Marijuana G. Sticht and H. Käferstein Institute of Legal Medicine, University of Cologne, Melatengürtel 60-62, D Köln, Germany ABSTRACT The recommendation for laying down a limiting value of tetrahydrocannabinol concentration in plasma raises the question of dose-effect-relations. For this an essential precondition is the determination of pharmacokinetic parameters as resorption, distribution and elimination constants as well as distribution volume and bioavailability. We have evaluated results of 5 studies which contain data relating to THC-levels in plasma after smoking of marijuana cigarettes with defined content of THC. The pharmacokinetic parameters developed out of these studies under presumption of a two compartment model leads to a time plot of average THC-concentrations as well as minimum and maximum curves at which the standard deviation of the pharmacokinetic parameters are taken into account. In particular during resorption and in the late elimination stage estimation of plasma levels of THC is accompanied by a wide dispersion. Nevertheless estimation of THCconcentrations out of the amount of consumed marijuana at a stated time or on the other hand interval out of THC-concentration in plasma is to be derived using the developed curves of THC-concentrations. INTRODUCTION The knowledge about influences of psychotropically active substances like narcotics and drugs on ability to drive is much less than about effects of alcohol. While alcohol is distributed nearly exclusively in the body water, the pharmacokinetics of most other substances is more complex because of their lipophility. One prediction for a better understanding of dose-effect-relations of drugs and other active agents is evaluation of pharmacokinetic models and determinations of corresponding datas. An open twocompartment model describes the course of plasma concentration of many psychotropically active agents. We have presented statistically evaluated pharmacokinetic parameters of 30 relevant drugs which allow to estimate the range of concentration in the various phases of plasma concentration-time curve (Käferstein et al. 1990, Graß 1989). Attempts in Germany for laying down a legal limiting value of tetrahydrocannabinol (THC) concentration in plasma raises the question of dose-effect-relations. For this an essential precondition is the determination of pharmacokinetic parameters as resorption, distribution and elimination constants as well as distribution volume (V d ) and bioavailability (B). Some pharmacokinetic data of THC after smoking of marijuana cigarettes are given by Chiang and Barnett (1984) but these values are not sufficient to plot a concentration-time curve. Some investigators have reported an elimination half-life of THC of 20 hours and more (Hunt and Jones 1980, Peat 1989). These results might be caused by the applied 397
2 methods for quantitation of THC. We have considered only studies with GC-MS estimation of THC because of the secure identification and quantitation by this way. RESULTS Studies on controlled smoking of marijuana permit estimation of most pharmacokinetic parameters as resorption, distribution, and elimination constant but not the distribution volume. This parameter is only deductible from intravenous administration because a high loss of THC should result from smoking and oral intake. Intravenous application Studies with intravenous administration of THC are performed by Hollister et al. (1981) and Lindgren et al. (1981). Unfortunately the authors documented not the individual body weights and the individual time concentration curves. In Table 1 the pharmacokinetic parameters calculated by our self provided computer program (Sticht et al. 1986) are presented. Table 1 Pharmacokinetic Parameters after IV-Application of THC (2 studies with 29 probands). Dose 5 mg THC, body weight unknown Probands β (h -1 ) α (h -1 ) V d (L) V c (L) (Hollister et al. 1981) (Lindgren et al. 1981) heavy users (Lindgren et al. 1981) light users Mean SD There is a very good agreement between the studies concerning the constant of distribution. But there are some differences between the light and the heavy users. Nevertheless it can not be said, that heavy users would eliminate THC faster than the other group. The mean volume of distribution is 236 L, but the two groups are clearly distinguishable. But this is difficult to interpret because the body weights are not known. Oral application We could find only one published study after oral intake of 20 mg THC (Hollister et al. 1981). The pharmacokinetic parameters are given in Table 2. The data were derived from average value curve. The bioavailability (B) is calculated with the mean volume of distribution from Table 1 and only 6% The constant of distribution seems to be much lower 398
3 than after intravenous injection. It could be possible that there is an overlapping of slow resorption, distribution and elimination. Table 2 Pharmacokinetic Parameters after Oral Intake of 20 mg THC Probands β (h -1 ) α (h -1 ) V c (L) t 0 (h) Ka (h -1 ) B% Smoking We have evaluated results of 6 studies which contain data relating to THC-levels in plasma after smoking of marijuana cigarettes with defined content of THC. The relevant data are demonstrated in Table 3. Included are the studies of Hollister et al. 1981, Chiang and Barnett 1984, Lindgren et al. 1981, Heishman et al. 1990, Huestis et al a, and Perez- Reyes et al Some studies although containing essential results were not considered for estimation of the means and standard deviations of pharmacokinetic parameters because they possess a too low number of data for differentiating between distribution and elimination phases (Möller et al. 1992) or the period of smoking was too long to assume an intake in points (McBurney et al. 1986). Only in some publications individual concentration-time curves are given. Because not all data are available in the several studies the number of probands must be different when calculating the pharmacokinetic parameters by us. Table 3 Pharmacokinetic Parameters after Smoking of Marijuana Cigarettes with Known Content of THC (derived from 6 studies with average value curves e.g. individual concentration-time curves) Probands Mean SD elimination constant β (h -1 ) distribution constant a (h -1 ) central distribution volume Vc(L) lag time t 0 (h) resorption constant Ka (h -1 ) bioavailability B (%) (at V d = 236 L) The constant of distribution in this collective is higher than after oral intake but still lower than after THC was applicated intravenously. The constant of elimination is between the data after oral and I.V. intake. The constant of resorption is - as it could be expected - much higher than after oral intake. 399
4 CONCLUSION For the calculation of pharmacokinetic parameters several valid data must be available. Only after I.V. injection the volume of distribution can be calculated. After oral intake or after smoking the bioavailability must be taken into account. Obviously the bioavailability is very poor after oral intake and very different after smoking. To calculate the distribution constant it is necessary in every case, that data in a very early phase after injection or smoking are available. At least 5 data in the first 30 minutes and additional 5 data between 60 and 240 minutes are necessary to calculate the distribution and elimination constants precisely. Most of the published studies do not fulfill these criteria and - in addition - they give not the measured individual concentrations but only average values. Nevertheless the pharmacokinetic parameters developed out of these studies under presumption of a two compartment model leads to a time plot of average THC-concentrations as well as minimum and maximum curves at which the standard deviation of the pharmacokinetic parameters are taken into account. In particular during resorption and in the late elimination stage estimation of plasma levels of THC is accompanied by a wide dispersion. Nevertheless estimation of THC-concentrations out of the amount of consumed marihuana at a stated time or on the other hand time interval out of THC-concentration in plasma is to be derived using the developed curves of THC-concentrations. After smoking of 20 mg THC through a person of 70 kg of body weight the following concentration ranges can be expected (Table 4). The range is much smaller than with the data achieved from model I of Huestis et al. (1992 b) because their data are independent from the dose and the body weight. In practise at least the body weight of a person involved in a traffic accident or suspected he had driven a motor vehicle under the influence of THC should be known. Table 4 Concentration ranges (ng/ml) at different times after smoking of THC. Our data are concerning a person of 70 kg of body weight and smoking of 20 mg THC. The data from Huestis et al. (1992 b) are independent from dose and body weight. t (h) This evaluation Huestis et al A correlation between the THC concentration in the serum and the main effects must be assumed. Then relevant effects on fitness to drive must be within the first 30 to 60 minutes after smoking a marijuana cigarette. If the government - as in Germany - is willing to punish a person when driving a motor vehicle within e.g. 4 hours after smoking THC, a limiting value of 8 ng THC/ml serum could be established. 400
5 REFERENCES Chiang, C.N., Barnett, G.: Marijuana effect and delta-9-tetrahydrocannabinol plasma level. Clin. Pharmacol. Ther. 36 (1984) Heishman, S.J., Huestis, M.A. Henningfield, J.E., Cone, E.J.: Acute and Residual Effects of Marijuana: Profiles of Plasma THC Levels, Physiological, Subjective, and Performance Measures. Pharmacology/Biochemistry and Behavior 37 (1990) Graß, H.: Computergestützte Analyse pharmakokinetischer Profile psychotroper Wirkstoffe unter besonderer Berücksichtigung rechtsmedizinischer Fragestellungen. Inaugural- Diss., Köln, 1989 Hollister, L.E., Gillespie, H.K., Ohlsson, A., Lindgren, J.-E., Wahlen, A., Agurell, S.: Do Plasma Concentrations of Delta-9-Tetrahydrocannabinol Reflect the Degree of Intoxication. J. Clin. Pharmacol. 2l(1981)171S-177S Huestis, M.A., Henningfield, J.E., Cone, E.J.: Blood Cannabinoids. I. Absorption of THC and Formation of 11-OH-THC and THCCOOH During and After Smoking Marijuana. J. Anal. Toxicol. 16 (1992 a) Huestis, M.A., Henningfield, J.E., Cone, E.J.: Blood Cannabinoids.II.Models for the prediction of time of marijuana exposure from plasma concentrations of A-9- tetrahydrocannabinol (THC) and 11-nor-9-carboxy-9-tetrahydrocannabinol (THCCOOH) J. Anal. Toxicol. 16 (1992 b) Hunt, A., Jones, R.T.: Tolerance and disposition of tetrahydrocannabinol in man. J. Pharmacol. Exp. Ther. 215 (1980) Käferstein, H., Sticht, G., Staak, M.: Psychotropically active substances and driving incapability - A pharmaco-kinetic computer model. In: M.W.Bud Perrine (ed.) Alcohol, drugs and traffic safety. National safety council (1990) Lindgren, J.E., Ohlsson, A., Agurell, S., Hollister, L., Gillespie, H.: Clinical effects and plasma levels of delta-9-tetrahydrocannabinol (delta-9-thc) in heavy and light users of cannabis. Psychopharmacol. 74 (1981) McBurney, L.J., Bobbie, B.A., Sepp, L.A.: GC/MS and EMIT Analyses for A-9- Tetrahydrocannabinol Metabolites in Plasma and Urine of Human Subjects. J. Anal. Toxicol. 10 (1986) Möller, M.R., Dörr, G., Warth, S.: Simultaneous Quantitation of Delta-9- tetrahydrocannabinol (THC) and 11 -Nor-9-carboxy-delta-9-tetrahydrocannabinol (THC-COOH) in Serum by GC/MS Using Deuterated Internal Standards and its Application to a Smoking Study and Forensic Cases. J. Forens. Sci. 37 (1992) Peat M.A. In: Advances in Analytical Toxicology, Vol. II. In: R.C. Baselt (ed.) Yearbook Medical Publishers, Chicago, 1989, pp Perez-Reyes, M., DiGuiseppi, S., Davis, K.H., Schindler, V., Cook, C.E.: Comparison of effects of marihuana cigarettes of three different potencies. Clin. Pharmacol. Ther. 31 (1982)
6 Sticht, G., Staak, M., Käferstein, H.: Die Ermittlung pharmakokinetischer Konstanten aus Wirkstoffspiegeln am Beispiel des Tetrazepam. In: Eisenmenger, W., Liebhardt, E., Schuck, M. (eds.) Festschrift für W. Spann (1986) Springer Verlag, Berlin Heidelberg New York 402
MARIHUANA AND DRIVING: WHAT IS THE SIGNIFICANCE OF CANNABINOID CONCENTRATIONS? * * A. McBay, M.D. ; and A. P. Mason SYNOPSIS
MARIHUANA AND DRIVING: WHAT IS THE SIGNIFICANCE OF CANNABINOID CONCENTRATIONS? * * A. McBay, M.D. ; and A. P. Mason SYNOPSIS It has been inferred that significant driving impairment can result from marihuana
More informationComparison of Cannabinoid Pharmacokinetic Properties in Occasional and Heavy Users Smoking a Marijuana or Placebo Joint
Comparison of Cannabinoid Pharmacokinetic Properties in Occasional and Heavy Users Smoking a Marijuana or Placebo Joint Stefan W. Toennes 1, *, Johannes G. Ramaekers 2, Eef L. Theunissen 2, Manfred R.
More informationIdentifying New Cannabis Use with Urine Creatinine- Normalized THCCOOH Concentrations and Time Intervals Between Specimen Collections *
Identifying New Cannabis Use with Urine Creatinine- Normalized THCCOOH Concentrations and Time Intervals Between Specimen Collections * Michael L. Smith 1, Allan J. Barnes 2, and Marilyn A. Huestis 2,
More informationMedicines and Driver Fitness - Findings from a Metaanalysis of Experimental Studies as Basic Information to Patients, Physicians and Experts
Medicines and Driver Fitness - Findings from a Metaanalysis of Experimental Studies as Basic Information to Patients, Physicians and Experts G Berghaus, B-L Guo Institute of Forensic Medicine, University
More informationIMPORTANCE OF Q UANTITATIVE ESTIM ATIO N OF OPIATES AND C ANN ABIN OIDES FOR DETERM INATIO N OF DR IVIN G PERFORMANCE
IMPORTANCE OF Q UANTITATIVE ESTIM ATIO N OF OPIATES AND C ANN ABIN OIDES FOR DETERM INATIO N OF DR IVIN G PERFORMANCE M. S taak, H. K äferstein, G. Sticht Institute of Forensic Medicine, Melatengürtel
More informationMarijuana and DWI 1/31/2017. Smoking Vaporizing Ingestion of edibles. Hello Mary Jane. Summary. Marijuana and Public Policy
Hello Mary Jane Marijuana and DWI Using Science to Cut Through the Smoke Marijuana and Public Policy Summary Between 25% and 60% of cartel profits come from Marijuana RAND Corporation study vs. White House
More informationMarijuana and DWI. Using Science to Cut Through the Smoke
Marijuana and DWI Using Science to Cut Through the Smoke Hello Mary Jane Marijuana and Public Policy Between 25% and 60% of cartel profits come from Marijuana RAND Corporation study vs. White House Office
More informationEffects of Cannabis on Psychomotor Skills and Driving Performance - a Metaanalysis of Experimental Studies
Effects of Cannabis on Psychomotor Skills and Driving Performance - a Metaanalysis of Experimental Studies G Berghaus, N Scheer, P Schmidt Institute of Forensic Medicine, University of Cologne, Melatengürtel
More informationPrediction of THC Plasma and Brain Concentrations following. Marijuana Administration: Approach and Challenges
Prediction of THC Plasma and Brain Concentrations following Marijuana Administration: Approach and Challenges Contents: 1. Background and Significance 1.1. Introduction 1.2. THC - the primary chemical
More informationTemporal Indication of Marijuana Use Can Be Estimated From Plasma and Urine Concentrations of Ag-Tetrahydrocannabinol, 9
Temporal Indication of Marijuana Use Can Be Estimated From Plasma and Urine Concentrations of Ag-Tetrahydrocannabinol, 11-Hydroxy-A 9 -Tetrahydrocannabmol, and 11.Nor-Ag-Tetrahydrocannabinol-9-Carboxylic
More informationValidity Testing of the EZ-SCREEN Cannabinoid Test
Validity Testing of the EZ-SCREEN Cannabinoid Test Amanda J. Jenkins, Lorrie C. Mills, William D. Darwin, Marilyn A. Huestis, and Edward J. Cone* Addiction Research Center, NIDA, Baltimore, MD 21224 John
More informationMetabolism of Tetrahydrocannabinol in Frequent and Infrequent Marijuana Users
Metabolism of Tetrahydrocannabinol in Frequent and Infrequent Marijuana Users Peggy Kelly* School of Public Health, University of California-Berkeley, Biomedical and Environmental Health Sciences, Forensic
More informationDrug and Alcohol Dependence
Drug and Alcohol Dependence 105 (2009) 24 32 Contents lists available at ScienceDirect Drug and Alcohol Dependence journal homepage: www.elsevier.com/locate/drugalcdep Extended urinary 9-tetrahydrocannabinol
More informationImpaired Driving in Colorado: First Results from a Data Integration Initiative
Impaired Driving in Colorado: First Results from a Data Integration Initiative BECKY BUI OFFICE OF RESEARCH & STATISTICS DIVISION OF CRIMINAL JUSTICE COLORADO DEPARTMENT OF PUBLIC SAFETY Presentation to
More informationThe British Columbia Coroners Service is committed to conducting a thorough, independent examination of the factors contributing to death in order to
The British Columbia Coroners Service is committed to conducting a thorough, independent examination of the factors contributing to death in order to improve community safety and quality of life in the
More informationMarijuana-Laced Brownies: Behavioral Effects, Physiologic Effects, 9 ~1 and Urinalysis in Humans Following Ingesbon
I Marijuana-Laced Brownies: Behavioral Effects, Physiologic Effects, 9 ~1 and Urinalysis in Humans Following Ingesbon Edward J. Cone* and Rolley E. Johnson National Institute on Drug Abuse, Addiction Research
More informationThe clinical study of orally administered cannabinoids
ORIGINAL ARTICLE D 9 -Tetrahydrocannabinol, 11-Hydroxy- D 9 -Tetrahydrocannabinol and 11-Nor-9-Carboxy- D 9 -Tetrahydrocannabinol in Human Plasma After Robert S. Goodwin, DO, PhD,* Richard A. Gustafson,
More informationIntroduction. Abstract
A Comparison of Roche Kinetic Interaction of Microparticles in Solution (KIMS ) Assay for Cannabinoids and GC MS Analysis for 11-nor-9-Carboxy- 9 -Tetrahydrocannabinol * Timothy P. Lyons 1,, Catherine
More informationCannabinoid Related Mortality in Denver. James Caruso, MD Chief Medical Examiner/Coroner Denver, Colorado **No commercial/financial disclosures**
Cannabinoid Related Mortality in Denver James Caruso, MD Chief Medical Examiner/Coroner Denver, Colorado **No commercial/financial disclosures** Cannabis Legal Status March 2014 Fatality Case #1 19 y/o
More information[application note] Simultaneous detection and quantification of D 9 THC, 11-OH-D 9 T H C and D 9 THC-COOH in whole blood by GC tandem quadrupole MS
Simultaneous detection and quantification of D 9 THC, 11-OH-D 9 T H C and D 9 THC-COOH in whole blood by GC tandem quadrupole MS Marie Bresson, Vincent Cirimele, Pascal Kintz, Marion Villain; Laboratoire
More informationCANADIAN CANNABIS CRAZE (AND CONUNDRUM) Dr. Melissa Snider-Adler Chief Medical Review Officer DriverCheck Inc. Addiction Medicine Physician
CANADIAN CANNABIS CRAZE (AND CONUNDRUM) Dr. Melissa Snider-Adler Chief Medical Review Officer DriverCheck Inc. Addiction Medicine Physician AGENDA THC IMPAIRMENT A deep dive into THC vs. CBD Signs and
More informationNIH Public Access Author Manuscript Clin Chem. Author manuscript; available in PMC 2011 October 18.
NIH Public Access Author Manuscript Published in final edited form as: Clin Chem. 2009 December ; 55(12): 2180 2189. doi:10.1373/clinchem.2008.122119. Δ 9 -Tetrahydrocannabinol (THC), 11-Hydroxy-THC, and
More informationPharmacokinetics and Administration Modes of Cannabinoids A Challenge
Pharmacokinetics and Administration Modes of Cannabinoids A Challenge Prof. Dr. Rudolf Brenneisen University of Bern, Dept. Clinical Research www.phytopharm.dkf.unibe.ch rudolf.brenneisen@dkf.unibe.ch
More informationSee discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/
See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/41175273 Plasma and urine profiles of Δ9- tetrahydrocannabinol and its metabolites 11- hydroxy-δ9-tetrahydrocannabinol
More informationADDRESSING THE PROBLEM OF MARIJUANA- IMPAIRED DRIVING By Teri Moore May 2018
Cannabis Policy Policy Cannabis Series ADDRESSING THE PROBLEM OF MARIJUANA- IMPAIRED DRIVING By Teri Moore May 2018 States that have decriminalized or plan to decriminalize marijuana use are grappling
More information11-Nor-9-carboxy-THC Plasma Pharmacokinetics during and after Continuous High-Dose Oral THC
Clinical Chemistry 55:12 2180 2189 (2009) Drug Monitoring and Toxicology 9 -Tetrahydrocannabinol (THC), 11-Hydroxy-THC, and 11-Nor-9-carboxy-THC Plasma Pharmacokinetics during and after Continuous High-Dose
More informationDo D 9 -tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users?add_
RESEARCH REPORT doi:10.1111/j.1360-0443.2009.02705.x Do D 9 -tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users?add_2705 1..8 Erin L. Karschner 1, Eugene W. Schwilke 1, Ross
More informationSame Roads, Same Cannabis, Slightly New Context
Same Roads, Same Cannabis, Slightly New Context DR. DANIEL BEAR OCTOBER 18, 2018 @PROFDANBEAR Agenda 1. What should you expect with the new system 2. What do we know about cannabis and driving 3. What
More informationThe publisher's final edited version of this article is available at Addiction See other articles in PMC that cite the published article.
PMCID: PMC2784185 NIHMSID: NIHMS134593 Do Δ9-Tetrahydrocannabinol Concentrations Indicate Recent Use in Chronic Cannabis Users? Erin L. Karschner, B.A.,1 Eugene W. Schwilke, B.S.,1 Ross H. Lowe, Ph.D.,1
More informationCannabis, Cannabinoids and Driving
Cannabis, Cannabinoids and Driving What is the affect of cannabinoids on driving. The FDA has the best answer. It s apparent that the FDA does not believe that the mere presence of cannabinoids or their
More informationNIH Public Access Author Manuscript Addiction. Author manuscript; available in PMC 2010 December 1.
NIH Public Access Author Manuscript Published in final edited form as: Addiction. 2009 December ; 104(12): 2041 2048. doi:10.1111/j.1360-0443.2009.02705.x. Do Δ 9 -Tetrahydrocannabinol Concentrations Indicate
More informationTHOUGHTS FROM WASHINGTON STATE
THOUGHTS FROM WASHINGTON STATE COURTNEY POPP Legal Advisor, King Co Sheriff s Office Adv Training Unit & Washington State Traffic Safety Resource Prosecutor Courtney.popp@kingcounty.gov KNOW THE ISSUE
More informationCooking Meth and Doctor Shopping: The Challenges of Managing Prescription Therapeutics
Cooking Meth and Doctor Shopping: The Challenges of Managing Prescription Therapeutics James H. Nichols, PhD, DABCC, FACB Professor of Pathology, Microbiology, and Immunology Medical Director, Clinical
More informationMarijuana and motor vehicle crash research: Current knowledge, challenges, and opportunities
Marijuana and motor vehicle crash research: Current knowledge, challenges, and opportunities Jennifer M. Whitehill, Ph.D. Assistant Professor Health Promotion and Policy April 2, 2018 Outline Local policy
More informationDavid M. Schwope 1, Wendy M. Bosker 2, Johannes G. Ramaekers 2, David A. Gorelick 1 and Marilyn A. Huestis 1 *
Journal of Analytical Toxicology 2012;36:405 412 doi:10.1093/jat/bks044 Advance Access publication May 15, 2012 Article Psychomotor Performance, Subjective and Physiological Effects and Whole Blood D 9
More informationPlasma Cannabinoid Pharmacokinetics following Controlled Oral 9 -Tetrahydrocannabinol and Oromucosal Cannabis Extract Administration
Clinical Chemistry 57:1 66 75 (11) Drug Monitoring and Toxicology Plasma Cannabinoid Pharmacokinetics following Controlled Oral 9 -Tetrahydrocannabinol and Oromucosal Cannabis Extract Administration Erin
More informationDrug Profiles of Apprehended Drivers in Victoria
Drug Profiles of Apprehended Drivers in Victoria J Gerostamoulos, P McCaffrey, O H. Drummer and M Odell*. Victorian Institute of Forensic Medicine, Department of Forensic Medicine, Monash University, 57-83
More informationScreening for Drivers under the Influence of Drugs The new Drugwipe for Sweat and Saliva Testing
Screening for Drivers under the Influence of Drugs The new Drugwipe for Sweat and Saliva Testing F. Aberl and R. Zimmermann Securetec Detektions-Systeme AG, Rosenheimer Landstr. 129, D-85521 Ottobrunn,
More informationPharmacokinetic simulations for forensic toxicological evaluation and expertise
Pharmacokinetic simulations for forensic toxicological evaluation and expertise Stefan W. Toennes Institute of Forensic Toxicology, University of Frankfurt/Main, Kennedyallee 14, 6596 Frankfurt/Main (Germany),
More informationPlasma Cannabinoid Pharmacokinetics After Controlled Smoking and Ad libitum Cannabis Smoking in Chronic Frequent Users
Journal of Analytical Toxicology 2015;39:580 587 doi:10.1093/jat/bkv082 Special Issue Plasma Cannabinoid Pharmacokinetics After Controlled Smoking and Ad libitum Cannabis Smoking in Chronic Frequent Users
More informationOral Fluid and Plasma Cannabinoid Ratios after Around-the-Clock Controlled Oral
Clinical Chemistry 57:11 1597 1606 (2011) Drug Monitoring and Toxicology Oral Fluid and Plasma Cannabinoid Ratios after Around-the-Clock Controlled Oral 9 -Tetrahydrocannabinol Administration Garry Milman,
More informationLessons Learned from Colorado. Jen Knudsen Colorado Traffic Safety Resource Prosecutor
Lessons Learned from Colorado Jen Knudsen Colorado Traffic Safety Resource Prosecutor Traffic Safety Resource Prosecutor Work with national experts on traffic safety issues; Present training including
More informationUpdate on Marijuana Research. Source:
Update on Marijuana Research Source: http://www.hightimes.com/read/radical-rant-truth-about-marijuana-and-driving Today: Drugged driving (DD) has received national attention, because of state legalization
More informationCan "oral fluid" be used instead of "urine" for rapid screening of drug of abuse: a prospective pilot study
Hong Kong Journal of Emergency Medicine Can "oral fluid" be used instead of "urine" for rapid screening of drug of abuse: a prospective pilot study ATY Chow, VCH Ng, FL Lau Introduction: Spot urine tests
More informationOn-site testing of cannabis. A controlled study after smoking cannabis. Per Mansson, Biosensor Applications Sweden
Per Mansson, Biosensor Applications Sweden Magnus Nygren Biosensor Applications Sweden Carl Lundberg, APAC Security Pty Ltd, Australia Jan Ramaekers, Faculty of Psychology and Neuroscience, Maastricht
More informationMedibles. Objectives. What is the definition of a Medible? 10/24/2017. Define medibles. Explain Cannabinoids in the human system
Medibles Kimberly Marcus, RN.,BSN. Objectives Define medibles Explain Cannabinoids in the human system Discuss adverse Effects of Marijuana in Pediatrics Discuss Treatment for overdose of Marijuana in
More informationDrug-Impaired Driving in the United States
Drug-Impaired Driving in the United States What is the Drug-Impaired Driving Learning Centre (DIDLC)? The Drug Impaired Driving Learning Centre (DIDLC) is a fully bilingual, web-based educational resource
More informationPhencyclidine Blood Concentrations in DRE Cases*
Phencyclidine Blood Concentrations in DRE Cases* G.W. Kunsman 1,t, B. tevine 1,2, A. Costantino 3, and M.L. Smith 1 I Division of Forensic Toxicology, Armed Forces Institute of Pathology, 6825 16th St
More informationDETERMINATION OF CANNABINOIDS, THC AND THC-COOH, IN ORAL FLUID USING AN AGILENT 6490 TRIPLE QUADRUPOLE LC/MS
FORENSICS AND TOXICOLOGY ANALYSIS DETERMINATION OF CANNABINOIDS, THC AND THC-COOH, IN ORAL FLUID USING AN AGILENT 6490 TRIPLE QUADRUPOLE LC/MS Solutions for Your Analytical Business Markets and Applications
More informationDetection of synthetic cannabinoids in hair
Detection of synthetic cannabinoids in hair Alberto Salomone Lisbon, 28 th May 2015 Rise of NPS Arise of critical situations Acute intoxication Workplace testing Driving re-licensing Anti-doping analyses
More informationSuite 300, Washington, DC Synopsis... One or more drugs were detected in 81 percent of440. male drivers, aged 15-34, killed in motor vehicle
ARTICLES-GENERAL Drugs in Fatally Injured Young Male Drivers ALLAN F WILLIAMS, PhD MICHAEL A. PEAT, PhD DENNIS J. CROUCH, BS JOANN K. WELLS, BA BRYAN S. FINKLE, PhD Dr. Williams and Ms. Wells are with
More informationAssessment of Driving Impairment from Cannabis
Assessment of Driving Impairment from Cannabis Stephen Schmitz, PhD, MA Forensic Neuropsychologist Director, The Brain and Behavior Clinic - Denver and Boulder Clinical and Scientific Advisor, DriveABLE
More informationTreatment of Tourette's Syndrome with D 9 -Tetrahydrocannabinol (THC): A Randomized Crossover Trial
K. R. Müller-Vahl 1 U. Schneider 1 A. Koblenz 1 M. Jöbges 2 H. Kolbe 2 T. Daldrup 3 H. M. Emrich 1 Treatment of Tourette's Syndrome with D 9 -Tetrahydrocannabinol (THC): A Randomized Crossover Trial Anecdotal
More informationEnding Marijuana Prohibition/ The Effects on Impaired Driving. Colorado Highway Safety Office
Ending Marijuana Prohibition/ The Effects on Impaired Driving Colorado Highway Safety Office Glenn Davis: Littleton Police, Littleton Colorado: 1979-2004 Agent South Metro Drug Task Force Detective DRE
More informationPossibility of Use a Saliva for Determination Ethanol and Opiates
Possibility of Use a Saliva for Determination Ethanol and Opiates Wojciech Piekoszewski 1,2, Wojciech Gubała 1, Ewa Janowska 1, Janusz Pach 3, Dariusz Zuba 1 1 Institute of Forensic Research, Westerplatte
More informationINVOLVEMENT OF DRUGS IN ACCIDENT CAUSATION
INVOLVEMENT OF DRUGS IN ACCIDENT CAUSATION Jim GEROSTAMOULOS, Helen BATZIRIS, Olaf H. DRUMMER Victorian Institute of Forensic Medicine and Department of Forensic Medicine, Monash University, Southbank,
More informationAltering Perception and Dirty Deeds. Forensic Science Part #D
Bell-Ringer Forensic Science What are the classifications of Heroin/Cocaine? What is the primary system these types of drugs effect? What is the typical cause of death with overdose> Altering Perception
More informationProposal for a COUNCIL DECISION
EUROPEAN COMMISSION Brussels, 31.8.2016 COM(2016) 548 final 2016/0262 (NLE) Proposal for a COUNCIL DECISION on subjecting the new psychoactive substance methyl 2-[[1-(cyclohexylmethyl)-1Hindole-3-carbonyl]amino]-3,3-dimethylbutanoate
More informationPuget Sound Educational Service District
Puget Sound Educational Service District Before we begin..thank you! Agenda-Introductions and Reflection Marijuana Prevention Closing and Reflection Why Are We Here? Let s Hear From You. Name. School/Work/Community
More informationScreening of Antihistamine Agents (Diphenhydramine) with Blood and Urine Samples by REMEDi-HS System
Screening of Antihistamine Agents (Diphenhydramine) with Blood and Urine Samples by REMEDi-HS System Ohtsuji M, Ohshima T, Takayasu T, Nishigami J, Kondo T, Lin Z, Minamino T Department of Legal Medicine,
More informationClinical and laboratory diagnostic criteria for driving licence regranting.
Clinical and laboratory diagnostic criteria for driving licence regranting. R. Snenghi, M. M ontisci, F. Castagna, L. Tedeschi and S. D. Ferrara Centre of Behavioural and Forensic Toxicology, University
More informationHuman Cannabinoid Pharmacokinetics
1770 REVIEW Human Cannabinoid Pharmacokinetics by Marilyn A. Huestis Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, NIH, 5500 Nathan Shock Drive, Baltimore,
More informationPassive Cannabis Smoke Exposure and Oral Fluid Testing
Journal of Analytical Toxicology, VoL 28, October 2004 Passive Cannabis Smoke Exposure and Oral Fluid Testing Sam Niedbala 1, Keith Kardos 1, Sal Salamone 1, Dean Fritch 1, Matth Bronsgeest 1, and Edward
More information2017 Oregon Dental Conference Course Handout
2017 Oregon Dental Conference Course Handout Caroline DeVincenzi, DMD, & Barry Taylor, DMD, FAGD, FACD, CDE Course 8107: Green Dentistry: THC and Teeth? What you Need to Know About Cannabis Thursday, April
More informationIT S HIGH TIME: A COMMON SENSE APPROACH TO MARIJUANA-IMPAIRED DRIVING
IT S HIGH TIME: A COMMON SENSE APPROACH TO MARIJUANA-IMPAIRED DRIVING by Teri Moore and Adrian Moore, Ph.D. January 2019 Reason Foundation s mission is to advance a free society by developing, applying
More informationCannabis in the Workplace
Cannabis in the Workplace Ryan Vandrey, PhD Johns Hopkins University School of Medicine Disclosures Paid consultant to Zynerba Pharmaceuticals, Battelle Memorial Institute None of my consulting is directly
More informationPatient-Centered Urine Drug Testing. Douglas Gourlay, MD, MSc, FRCPC, FASAM
Patient-Centered Urine Drug Testing Douglas Gourlay, MD, MSc, FRCPC, FASAM Declaration of Potential Conflict of Interest The content of this presentation is non- commercial and does not represent any conflict
More informationSmartNotes. Why test for synthetic cannabinoids? Synthetic Cannabinoids Facts
DIAGNOSTICS Synthetic Cannabinoids SmartNotes Why test for synthetic cannabinoids? Synthetic Cannabinoids Facts Largest group of New Psychoactive Substances (NPS) on the market Mind-altering chemicals
More informationApplication. Detection of Cannabinoids in Oral Fluid Using Inert Source GC/MS. Introduction. Authors. Abstract. Forensic Toxicology
Detection of Cannabinoids in Oral Fluid Using Inert Source GC/MS Application Forensic Toxicology Authors Christine Moore, Sumandeep Rana, and Cynthia Coulter Immunalysis Corporation 829 Towne Center Drive
More informationEffective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature)
1 Policy #: 803 (PLH-803-02) Effective Date: NA Reviewed Date: 4/11/2008 Subject: URINE DRUG SCREENS Approved by: Laboratory Executive Director, Ed Hughes (electronic signature) Approved by: Laboratory
More informationPHARMACOKINETIC STUDY OF DEXTROMETHORPHAN WITH URINARY EXCRETION
PHARMACOKINETIC STUDY OF DEXTROMETHORPHAN WITH URINARY EXCRETION Heesun CHUNG, Wonkyung YANG, Hwakyung CHOI, Wontack JIN, Sihnyoung SIHN, Youngchan YOO National Institute of Scientific Investigation, Seoul,
More informationORAL FLUID DRUG TESTING
detection technologies for the new millennium ORAL FLUID DRUG TESTING Dean F. Fritch, Ph.D., DABFT, DABCC-TC Manager of Technical & Analytical Services TESTING FOR DRUGS OF ABUSE Tests for imairment/drug-induced
More informationCANNABIS AND CANADA S CHILDREN AND YOUTH CPS Podcast
CANNABIS AND CANADA S CHILDREN AND YOUTH CPS Podcast Developed by KEON MA and Dr. CHRISTINA GRANT for PedsCases.com July 6, 2018 INTRODUCTION: Keon: On June 21, 2018, Bill C-45, also known as the Cannabis
More informationEffects of Cannabis on Driving
Effects of Cannabis on Driving What is the Drug-Impaired Driving Learning Centre (DIDLC)? The Drug Impaired Driving Learning Centre (DIDLC) is a fully bilingual, web-based educational resource that was
More informationDetection of Cannabinoids in Oral Fluid with the Agilent 7010 GC-MS/MS System
Application Note Forensics, Workplace Drug Testing Detection of Cannabinoids in Oral Fluid with the Agilent 7010 GC-MS/MS System Authors Fred Feyerherm and Anthony Macherone Agilent Technologies, Inc.
More informationEffects of Central Nervous System Depressants on Driving
Effects of Central Nervous System Depressants on Driving What is the Drug-Impaired Driving Learning Centre (DIDLC)? The Drug Impaired Driving Learning Centre (DIDLC) is a fully bilingual, web-based educational
More informationForensic Toxicology. Chapter 17. Mrs. Svedstrup
Forensic Toxicology Chapter 17 Mrs. Svedstrup Forensic Toxicology Toxicology is study of harmful effects of drugs and poisons on living things Forensic toxicology is legal application of toxicology to
More informationOxymorphone Distribution in Biological Matrices: A Collection of Case Studies
Oxymorphone Distribution in Biological Matrices: A Collection of Case Studies Brian Simons, Forensic Toxicologist Montgomery County Coroner s Office / Miami Valley Regional Crime Laboratory May 1, 2008
More informationPharmacokinetics and Disposition of UDM Comparison of Various Sources for Drug Testing: Urine, Blood, Hair, Saliva. Edward J. Cone, Ph.D.
Pharmacokinetics and Disposition of UDM Comparison of Various Sources for Drug Testing: Urine, Blood, Hair, Saliva Edward J. Cone, Ph.D. Johns Hopkins School of Medicine, Baltimore, MD & ConeChem Research,
More informationCannabis and driving: Future perspectives. JG Ramaekers, President-elect, InternationaI Council on Alcohol, Drugs and Traffic Safety (ICADTS)
Cannabis and driving: Future perspectives JG Ramaekers, President-elect, InternationaI Council on Alcohol, Drugs and Traffic Safety (ICADTS) ICADTS activities relating to cannabis and driving Working group
More informationThe concentration of oxazepam and oxazepam glucuronide in oral fluid, blood and serum after controlled administration of 15 and 30 mg oxazepam
British Journal of Clinical Pharmacology DOI:1.1111/j.1365-2125.28.3252.x The concentration of oxazepam and oxazepam glucuronide in oral fluid, blood and serum after controlled administration of 15 and
More informationOn-the-road driving tests and neurocognitive tests for measuring the effects of cannabis on driving
On-the-road driving tests and neurocognitive tests for measuring the effects of cannabis on driving JG Ramaekers Dept Neuropsychology & Psychopharmacology, Faculty of Psychology & Neuroscience, Maastricht
More informationFrequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up
Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up Dr. Bhushan M. Kapur Associate Professor Department of Laboratory Medicine and Pathobiology, Faculty
More informationAbstract I. Introduction
Detection of the Marijuana Metabolite 11-Nor-A9- Tetrahydrocannabinol-9-Carboxylic Acid in Oral Fluid Specimens and Its Contribution to Positive Results in Screening Assays Christine Moore 1,*, Wayne Ross
More informationDrug identification performance on the basis of observable signs and symptoms
Accident Analysis and Prevention 37 (2005) 843 851 Drug identification performance on the basis of observable signs and symptoms David Shinar, Edna Schechtman Industrial Engineering and Management, Ben
More informationAlcoholism markers in their relation to prevention and rehabilitation
Alcoholism markers in their relation to prevention and rehabilitation by M. Staak, R. Iffland Institute of Legal Medicine, University at Cologne, Melatengiirtel 60-62, W - 5000 Köln 30, Germany Alcohol
More informationDetermination of Ag-THC in Whole Blood using Gas Chromatography-Mass Spectrometry
Journal of Analytical Toxicology, Vo!. 26, November/December 2002 Determination of Ag-THC in Whole Blood using Gas Chromatography-Mass Spectrometry Technical Note J Mark Hok Chi Chu and Olaf H. Drummer*
More informationForensic Toxicology. William C. Bress, PhD State Toxicologist Adjunct Assistant Professor Department of Biology University of Vermont
Forensic Toxicology William C. Bress, PhD State Toxicologist Adjunct Assistant Professor Department of Biology University of Vermont History of Forensic Toxicology Paracelsus (1493-1541) 1541) Orfila (1787-1853)
More informationTECHNICAL NOTE TOXICOLOGY. Kari Declues, 1 M.S.; Shelli Perez, 1 M.S.; and Ariana Figueroa, 1 M.S.
TECHNICAL NOTE J Forensic Sci, 2017 doi: 10.1111/1556-4029.13550 Available online at: onlinelibrary.wiley.com TOXICOLOGY Kari Declues, 1 M.S.; Shelli Perez, 1 M.S.; and Ariana Figueroa, 1 M.S. A Two-Year
More informationCozart DDS Drug Detection System On-site Saliva Drug Testing
Cozart DDS Drug Detection System On-site Saliva Drug Testing www.siemens.com Siemens Healthcare Diagnostics Drug Testing, under the Cozart brand name, has more than a 10-year legacy of providing an extensive
More informationCannabis in the Community
Department of Pediatrics Cannabis in the Community The Unintended Consequences of Increased Marijuana Availability on the Pediatric Population Karen Buchi, MD Professor of Pediatrics Chair, University
More informationDriving Drunk, Driving High: A Comparison of Student Attitudes Towards Driving while Drunk Versus Driving while High on Cannabis
Driving Drunk, Driving High: A Comparison of Student Attitudes Towards Driving while Drunk Versus Driving while High on Cannabis D. Patton & D. Brown Research and Quality Monitoring, Addictions Foundation
More informationDRIVERS INVOLVED IN ACCIDENTS AND SUSPECTED UNDER INFLUENCE
DRIVERS INVOLVED IN ACCIDENTS AND SUSPECTED UNDER INFLUENCE R. Giorgetti, S. Zancaner, S. Maietti, L. Tedeschi, P. Benato, S. D. Ferrara. Dipartimento di Medicina Ambientale e Sanità Pubblica, sede di
More informationORAL FLUID DRUG TESTING Dean F. Fritch, Ph.D., DABFT, DABCC-TC Manager of Technical & Analytical Services
detection technologies for the new millennium ORAL FLUID DRUG TESTING Dean F. Fritch, Ph.D., DABFT, DABCC-TC Manager of Technical & Analytical Services TESTING FOR DRUGS OF ABUSE Tests for imairment/drug-induced
More informationCannabinoid Quantitation Using an Agilent 6430 LC/MS/MS
Cannabinoid Quantitation Using an Agilent 643 LC/MS/MS Application Note Forensics Authors Jason Hudson, Ph.D., James Hutchings, Ph.D., and Rebecca Wagner, Ph.D. Virginia Department of Forensic Science
More informationQuantitative Analysis of THC and Main Metabolites in Whole Blood Using Tandem Mass Spectrometry and Automated Online Sample Preparation
Quantitative Analysis of THC and Main Metabolites in Whole Blood Using Tandem Mass Spectrometry and Automated Online Sample Preparation Valérie Thibert, Bénédicte Duretz Thermo Fisher Scientific, Courtaboeuf,
More informationAn Investigation of the Stability of Free and Glucuronidated -Nor-Ag-Tetrahydrocannabinol-9- carboxyl,c Acid lauthentic Urine Samples
An Investigation of the Stability of Free and Glucuronidated -Nor-Ag-Tetrahydrocannabinol-9- carboxyl,c Acid lauthentic Urine Samples Gisela Skopp 1,* and Lucia Pi~tsch 2 I Institute of Forensic Medicine,
More informationDetection of Drugs-of-Abuse by Tandem Mass Spectrometry.
Detection of Drugs-of-Abuse by Tandem Mass Spectrometry. Dr Tim Laurens MSc.Chem(Pretoria), Ph.D. Chem (Pretoria), MSc.Toxicology (Surrey,UK) FRSChem, MFSSoc Email: laurensj@lancet.co.za / tim.laurens@up.ac.za
More informationThe Effects of Cannabis on the Developing Brain: From Prenatal Development Through Early Adulthood
The Effects of Cannabis on the Developing Brain: From Prenatal Development Through Early Adulthood Kyle E. Ferguson, Ph.D. Providence St. Peter Family Medicine Residency Program October 20, 2014 Disclosure
More informationDriving Under The Influence Of Drugs In Ireland: A Growing And Significant Danger
Driving Under The Influence Of Drugs In Ireland: A Growing And Significant Danger D.A.Cusack, G.Harrington, P.Furney, K.Flynn and C.P.Leavy Medical Bureau of Road Safety, Department of Forensic Medicine,
More information